A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Uncontrolled Hypertension

Clinical trial NCT07654140 · RECRUITING

Trial details

NCT number: NCT07654140
Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Uncontrolled Hypertension

Start date: 2025-12-09
Primary completion: 2027-03-01
Enrollment: 252

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.